PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10840459-5	2000	IP injection of the NK1 receptor antagonist CP 99994 (10 mg./kg.	3-(2-methoxybenzylamino)-2-phenylpiperidine	44-52	substance-P receptor	Cavia porcellus	20-32	
11266378-7	2001	Mobilization of the receptor by SP was blocked by the NK(1)-receptor antagonist CP99994.	3-(2-methoxybenzylamino)-2-phenylpiperidine	80-87	substance-P receptor	Cavia porcellus	54-68	
9641542-7	1998	Pretreatment of sensitized guinea-pigs with the NK1 receptor antagonists CP99994 (4 mg kg(-1), i.p.	3-(2-methoxybenzylamino)-2-phenylpiperidine	73-80	substance-P receptor	Cavia porcellus	48-60	
10502070-4	1999	Binding to NK(1) receptors was blocked by the NK(1) receptor antagonist, CP-99994.	3-(2-methoxybenzylamino)-2-phenylpiperidine	73-81	substance-P receptor	Cavia porcellus	11-25	
9676748-5	1998	Substance P could be excluded as inhibitory transmitter because the effect of SIN-1 remained unchanged in the presence of the NK1 receptor antagonist CP 99994 (100 nM).	3-(2-methoxybenzylamino)-2-phenylpiperidine	150-158	substance-P receptor	Cavia porcellus	126-138	
9641542-15	1998	Pretreatment with the NK1 receptor antagonists CP99994 or SR140333 before challenge prevented this increase.	3-(2-methoxybenzylamino)-2-phenylpiperidine	47-54	substance-P receptor	Cavia porcellus	22-34	
9466466-4	1998	In addition, ODQ (1 microM) increased the electrically-evoked tachykininergic and cholinergic muscle contractions as measured in the presence of scopolamine (100 nM) or of the neurokinin-1 receptor antagonist CP 99994 (100 nM), respectively.	3-(2-methoxybenzylamino)-2-phenylpiperidine	209-217	substance-P receptor	Cavia porcellus	176-197